Stanford Graduate School of Business (USA)
-
Novartis’ Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries’ Health Care Systems - Teaching Note
Chess, R; Luthre, JTeaching Note SGSB-E489TN-EEntrepreneurshipInternational healthcare and reimbursement systems underwent a radical transformation in the 2000s, resulting from growing financial pressures incited by economic depression and a steady rise in healthcare spending. This phenomenon was most pronounced in the United States, where the health-spending share of GDP rose from five percent in 1960 to 17.9 percent in 2011. In Organization for Economic Co-operation and Development (OECD) countries on a...Starting at €0.00
-
Ditto - Teaching Note
Fern Mandelbaum, Julieta DuekTeaching Note SGSB-E508TN-EEntrepreneurshipThe case tells the story of Kate Doerksen in her journey as founder and CEO of Ditto, an eyewear e-commerce company that introduced virtual fitting technology. The case covers the period from the founding of the company in 2010 to its situation in December 2012, when the company faced a number of decisions including facing lawsuits from a competitor and a patent troll. This case focuses on the following elements of Doerksen’s story: • How Doer...Starting at €0.00
-
Ditto
Fern Mandelbaum, Julieta DuekCase SGSB-E508-EEntrepreneurshipThe case tells the story of Kate Doerksen in her journey as founder and CEO of Ditto, an eyewear e-commerce company that introduced virtual fitting technology. The case covers the period from the founding of the company in 2010 to its situation in December 2012, when the company faced a number of decisions including facing lawsuits from a competitor and a patent troll. This case focuses on the following elements of Doerksen’s story: • How Doer...Starting at €8.20
-
Novartis’ Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries’ Health Care Systems
Chess, R; Luthre, JCase SGSB-E489-EEntrepreneurshipInternational healthcare and reimbursement systems underwent a radical transformation in the 2000s, resulting from growing financial pressures incited by economic depression and a steady rise in healthcare spending. This phenomenon was most pronounced in the United States, where the health-spending share of GDP rose from five percent in 1960 to 17.9 percent in 2011. In Organization for Economic Co-operation and Development (OECD) countries on a...Starting at €8.20